Results 301 to 310 of about 470,158 (371)

Distribution of Ophthalmology Grant Opportunities and Variation Amongst Subspecialties in Australia

open access: yes
Clinical &Experimental Ophthalmology, EarlyView.
Benjamin Cook   +3 more
wiley   +1 more source

Equity-enhanced glaucoma progression prediction from OCT with knowledge distillation. [PDF]

open access: yesNPJ Digit Med
Afolabi SO   +5 more
europepmc   +1 more source

Examining the use of analytics in healthcare operations management: A systematic and narrative literature review

open access: yesDecision Sciences, EarlyView.
Abstract Healthcare delivery is data intensive and data dependent, but hospitals have struggled to leverage data to improve operational performance. At the same time, healthcare researchers have been advancing the use of analytics in our publications. Unfortunately, there appears to be a substantial gap between the insights that we as researchers have ...
Bogdan Bichescu   +4 more
wiley   +1 more source

Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetes is increasingly reported as a cause of blindness and vision loss. However, the trends in the burden of blindness and vision loss attributed to diabetic retinopathy (DR) have yet to be fully elucidated. Materials and Methods Utilizing the latest data from the Global Burden of Disease Study 2021, we extracted prevalence and years ...
Yujie Pan   +4 more
wiley   +1 more source

Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP‐4 inhibitors: A multicentre, phase 4 randomized controlled trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the efficacy and safety of three triple‐combination therapies in patients with type 2 diabetes (T2D) inadequately controlled on metformin and a dipeptidyl peptidase‐4 (DPP‐4) inhibitor. Materials and methods This multicentre, prospective, randomised, open‐label, parallel‐group, phase 4 study included patients with T2D ...
Yun Kyung Cho   +10 more
wiley   +1 more source

Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide. [PDF]

open access: yesKlin Monbl Augenheilkd
Qi T   +5 more
europepmc   +1 more source

Glaucoma

open access: yesCleveland Clinic Journal of Medicine, 1949
openaire   +2 more sources

Home - About - Disclaimer - Privacy